Encyclopedia of Malaria

Living Edition
| Editors: Peter G. Kremsner, Sanjeev Krishna

Malaria Diagnostic Platform, ELISA

Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-8757-9_107-1



Enzyme-linked immunosorbent assay is a powerful diagnostic tool which, however, has only limited application in malaria diagnostics and research but may be the answer to a number of upcoming questions. This entry discusses potential applications and limitations of antigen and antibody detection by ELISA as a malaria diagnostic platform.


In the history of the analysis of biomolecules, immunoassays together with various chromatographic and more recently molecular techniques have probably been the most commonly used technologies. Immunoassays are well suited for qualitative and quantitative assays of a single, well-defined molecular group. As compared to most other available methods, immunoassays can be developed that use less complex equipment and can be used in a wider range of testing environments.

Immunoassays take advantage of a natural phenomenon in order to quantify...


Rapid Diagnostic Test Mass Drug Administration Entomological Inoculation Rate Malaria Diagnosis Indirect Fluorescent Antibody Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Basco L. Field application of in vitro assays sensitivity of human malaria parasites antimalarial drugs. Geneva: World Health Organization; 2007.Google Scholar
  2. Bruce-Chwatt LJ, Draper CC, Konfortion P. Seroepidemiological evidence of eradication of malaria from Mauritius. Lancet. 1973;2(7828):547–51.CrossRefPubMedGoogle Scholar
  3. Collins WE, Skinner JC, Jeffery GM. Studies on the persistence of malarial antibody response. Am J Epidemiol. 1968;87(3):592–8.PubMedGoogle Scholar
  4. Corran P, Coleman P, Riley E, Drakeley C. Serology: a robust indicator of malaria transmission intensity? Trends Parasitol. 2007;23(12):575–82.CrossRefPubMedGoogle Scholar
  5. Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, Griffin J, Cox J, Abeku T, Bousema T, Ghani AC, Drakeley C, Riley E. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J. 2008;7:195.PubMedCentralCrossRefPubMedGoogle Scholar
  6. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2008;102(14):5108–13.CrossRefGoogle Scholar
  7. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry. 1971;8(9):871–4.CrossRefPubMedGoogle Scholar
  8. Faddy HM, Seed CR, Faddy MJ, Flower RL, Harley RJ. Malaria antibody persistence correlates with duration of exposure. Vox Sang. 2013;104(4):292–8.CrossRefPubMedGoogle Scholar
  9. Kim JY, Kim HH, Na BK, Kim YJ, Sohn Y, Kim H, Kim TS, Lee HW. Estimating the malaria transmission of Plasmodium vivax based on serodiagnosis. Malar J. 2012;11:257.PubMedCentralCrossRefPubMedGoogle Scholar
  10. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344(26):1973–8.CrossRefPubMedGoogle Scholar
  11. Noedl H, Wongsrichanalai C, Wernsdorfer WH. Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 2003;19(4):175–81.CrossRefPubMedGoogle Scholar
  12. Noedl H, Yingyuen K, Laoboonchai A, Fukuda M, Sirichaisinthop J, Miller RS. Sensitivity and specificity of an antigen detection ELISA for malaria diagnosis. Am J Trop Med Hyg. 2006;75(6):1205–8.PubMedGoogle Scholar
  13. Pava Z, Echeverry DF, Díaz G, Murillo C. Large variation in detection of histidine-rich protein 2 in Plasmodium falciparum isolates from Colombia. Am J Trop Med Hyg. 2010;83(4):834–7.PubMedCentralCrossRefPubMedGoogle Scholar
  14. Seed CR, Kitchen A, Davis TM. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev. 2005;19(3):229–40.CrossRefPubMedGoogle Scholar
  15. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009;4(6):e6083.PubMedCentralCrossRefPubMedGoogle Scholar
  16. Van Weemen BK, Schuurs AH. Immunoassay using antigen-enzyme conjugates. FEBS Lett. 1971;15(3):232–6.CrossRefPubMedGoogle Scholar
  17. White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malaria J. 2011;10:297.CrossRefGoogle Scholar
  18. World Health Organization. Screening donated blood for transfusion-transmissible infections: recommendations. Geneva: World Health Organization; 2010.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Institute of Specific Prophylaxis and Tropical MedicineMedical University of ViennaViennaAustria